Sign in

    Brian S. Tyler

    Chief Executive Officer at Mckesson Corp
    Since April 1, 2019
    Age
    57 years
    Education
    Earned his Ph.D. in Economics from the University of Chicago, specializing in industrial organization, labor economics, and public finance/project evaluation.
    Tenure
    Has been with McKesson Corporation for 26 years, serving in various leadership roles including President, Chief Operating Officer, and since April 2019, the Chief Executive Officer.

    Also at Mckesson Corp

    BJV
    Britt J. Vitalone
    Executive Vice President and Chief Financial Officer
    LBS
    LeAnn B. Smith
    Executive Vice President and Chief Human Resources Officer
    ML
    Michele Lau
    Executive Vice President and Chief Legal Officer

    About

    Brian S. Tyler has built a distinguished career in the healthcare and pharmaceuticals industry, showcasing a deep understanding of business transformation and global operations. His leadership journey includes overseeing major strategic initiatives and steering diverse business units at McKesson Corporation, enabling him to develop a comprehensive perspective on corporate growth and operational excellence.

    His progression through various executive roles—ranging from President and Chief Operating Officer in North America to leadership positions in Europe—highlights his agility in navigating complex business landscapes and his commitment to driving sustainable business improvements.

    Beyond his principal role at McKesson, he contributes to the industry by serving on the boards of prominent organizations such as Republic Services, Inc. and the International Federation of Pharmaceutical Wholesalers. His active involvement in philanthropic endeavors, including the American Cancer Society’s CEOs Against Cancer group, underscores a long-term commitment to community and industry advancement.

    $MCK Performance Under Brian S. Tyler

    Past Roles

    OrganizationRoleDate RangeDetails
    McKesson Corporation President and Chief Operating Officer Aug 2018 – Mar 2019 Preceded his promotion to CEO.
    McKesson Europe AG Chairman of the Management Board 2017 – 2018 Leadership role in European operations.
    McKesson Corporation President and COO of McKesson Europe 2016 – 2017 Oversaw European business unit.
    McKesson Corporation President of North American Pharmaceutical Distribution and Services 2015 – 2016 Directed U.S. pharmaceutical distribution operations.
    McKesson Corporation Executive Vice President, Corporate Strategy and Business Development 2012 – 2015 Focused on corporate strategy initiatives.
    McKesson Corporation President of U.S. Pharmaceutical N/A [N/A]Role details not dated.
    McKesson Corporation President of McKesson Medical-Surgical N/A [N/A]Role details not dated.
    McKesson Corporation President of McKesson Specialty Health N/A [N/A]Role details not dated.

    External Roles

    OrganizationRoleDate RangeDetails
    Republic Services, Inc. Board of Directors N/A [N/A]Current active position outside MCK.

    Fixed Compensation

    Data from  FY 2024
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary$1,500,000 Annual (2024)Fixed base salary for FY2024
    401(k) Plan Match$13,200 Annual (2024)Matching contribution as per plan guidelines
    Nonqualified Deferred Compensation Plan Match$412,638 Annual (2024)Deferred compensation match for FY2024
    Financial Counseling Services$19,598 Annual (2024)Service benefit component for FY2024
    Executive Officer Security Policy$327,964 Annual (2024)Security policy benefit included in fixed compensation
    Other Perquisites and Severance Benefits$79,325 Annual (2024)Additional fixed benefits provided for FY2024

    Performance Compensation

    Data from  FY 2024

    Annual Cash Incentive (MIP)

    MetricWeightTargetResultPayout Contribution
    Adjusted EPS50% $27.44 122% Contributes ~61% of overall MIP payout
    Adjusted Operating Profit25% $4,901M 111% Contributes ~27.75% of overall MIP payout
    Free Cash Flow25% $3,627M 100% Contributes 25% of overall MIP payout
    • Eligible Earnings: $1,490,000
    • MIP Target (% of Salary): 185%
    • MIP Target Award: $2,756,500
    • MIP Payout Earned: 114% of target, resulting in $3,142,410
    • Vesting: No vesting; this is an annual cash incentive paid after fiscal year-end

    Performance Stock Units (PSUs)

    MetricWeightTarget/ValueAdditional Information
    Cumulative Adjusted EPS50% $79.17 (FY2022-FY2024) Performance benchmark over the period
    Average ROIC25% 17.54% (FY2022-FY2024) Reflects operational performance
    Total Shareholder Return (TSR)25% Relative position at 100th percentile Market-based measure including reinvested dividends
    • PSU Payout: 200% of target awards
    • Grant Date: May 23, 2023
    • Grant Date Fair Value: $8,100,237
    • Grant Date Stock Price: $393.14 per unit
    • PSU Target Awards: 19,084 units
    • Vesting Schedule: Three-year performance period; vests in May 2026

    Value of Stock Vesting upon Involuntary Termination in Connection with a Change in Control

    MetricValueAdditional Details
    Value of Stock Vesting$78,332,319 Triggered upon involuntary termination in connection with a Change in Control
    Threshold Shares9,542 Represents 50% of target PSU awards
    Target Shares19,084 Target number of PSU awards
    Maximum Shares38,168 200% of target; Market value at closing price of $536.85 equals $20,487,122
    Vesting ScheduleAccelerated upon Change in Control Originally scheduled to vest in May 2026 but accelerated if a Change in Control occurs